awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39255218-1D29A85A-4408-4F5D-83FC-E30A10503F0E
Q39255218-1D29A85A-4408-4F5D-83FC-E30A10503F0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-1D29A85A-4408-4F5D-83FC-E30A10503F0E
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy.
P2860
Q39255218-1D29A85A-4408-4F5D-83FC-E30A10503F0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-1D29A85A-4408-4F5D-83FC-E30A10503F0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a4057ecd1bb86321da419205b57f1c05eecca70
P2860
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib